CooperVision Canada Marks Fifth Year of Raising Awareness About Childhood Myopia and Treatment Options
For the fifth year in a row, CooperVision Canada is investing in educating parents and…
Bausch + Lomb Announces Publication of Phase 3 Data on LUMIFY Preservative Free Redness Reliever Eye Drops
Bausch + Lomb Corporation announced Ophthalmology and Therapy has published results from a phase 3 study which assessed the…
August is Children’s Eye Health and Safety Month at Prevent Blindness
As many families are preparing for a new school year, Prevent Blindness has declared August…
Opticians Association of Canada Issues Statement Regarding Blue Cross Partnership with KITS EYECARE
The Opticians Association of Canada (OAC) acknowledges the recent announcement by Blue Cross regarding their…
Alcon’s Latest Breakthrough Surgical Technology, Unity VCS, Receives Health Canada Approval
Alcon announced that UNITY Vitreoretinal Cataract System (VCS) has received Health Canada approval. This innovation is…
Introducing Q.REC — the Quality of Refractive Error Care Initiative Website
Every year, hundreds of millions are held back by uncorrected or poorly corrected refractive error,…
PulseSight Therapeutics Initiates First-in-Patient Trial for Revolutionary Dry AMD Treatment
PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery…
Alcon to Acquire LumiThera and Its Photobiomodulation Device for the Treatment of Early and Intermediate Dry Age-Related Macular Degeneration (AMD)
Alcon announced its intention to acquire LumiThera and its PBM device for the treatment of…
World Health Assembly: A Major Step Forward for Sensory Health
At the 78th World Health Assembly (19-27 May 2025), Member States endorsed a landmark resolution…
Bausch + Lomb Combines Patient Voices and New Survey Insights to Combat Persistent Misconceptions about Dry Eye
Bausch + Lomb Corporation launched “Eyes Tell the Story: The Impact of Dry Eye.” The…